Detection and monitoring of a concomitant atypical myeloproliferative disorder and chronic lymphocytic leukemia by flow-cytometric immunophenotyping.

Autor: McCoy JP Jr; Department of Pediatrics, Cooper Hospital-University Medical Center, UMDNJ-Robert Wood Johnson Medical School, Camden, USA., Johnson E, Catalano E, Blumstein L, Overton WR, Gryn J, Donaldson MH
Jazyk: angličtina
Zdroj: Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 1995 Nov; Vol. 119 (11), pp. 1038-43.
Abstrakt: Objective: To illustrate the utility of a broad panel of monoclonal antibodies to detect secondary processes or unexpected characteristics of the primary blood dyscrasia.
Design: Case report and discussion.
Setting: Regional academic medical center.
Patient: A 64-year-old man presenting with an apparent acute myeloid leukemia.
Interventions: Sequential immunophenotyping with a broad panel of monoclonal antibodies to monitor progression of disease and response to therapy.
Main Outcome Measure: Identification and monitoring of the two atypical populations in this patient with correlation to the clinical status of the patient.
Results: Identification of an unsuspected mature lymphoid clone and characterization of the evolution of the myelomonocytic clone.
Conclusion: The evolving mature lymphoid clone may have been overlooked in the context of a predominant atypical myeloproliferative process, particularly if a limited panel of monoclonal antibodies had been used for immunophenotyping. Sequential immunophenotyping was useful in monitoring the progression of each atypical process.
Databáze: MEDLINE